Fluvoxamine for Outpatient COVID-19 to Prevent Hospitalization: A Systematic Review and Meta-Analysis

Todd C. Lee, Simone Vigod, Émilie Bortolussi-Courval, Ryan Hanula, David R. Boulware, Eric J. Lenze, Angela M. Reiersen, Emily G. McDonald
doi: https://doi.org/10.1101/2021.12.17.21268008

Article usage

Article usage: December 2021 to December 2024

AbstractFullPdf
Dec 20216066221222
Jan 2022225744553
Feb 202244716213
Mar 2022327748
Apr 20221751361
May 20221131142
Jun 202270117
Jul 202292313
Aug 202298214
Sep 202290610
Oct 20225248
Nov 20223718
Dec 20225837
Jan 202350113
Feb 20234888
Mar 20233734
Apr 202338812
May 20231919
Jun 20233156
Jul 20231337
Aug 2023391412
Sep 20232756
Oct 20232119
Nov 202321104
Dec 202318610
Jan 20241844
Feb 202427511
Mar 202425411
Apr 202417710
May 20241725
Jun 202426511
Jul 20241149
Aug 202432511
Sep 202416613
Oct 20241098
Nov 2024351733
Dec 202416610
Back to top
Posted December 21, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Fluvoxamine for Outpatient COVID-19 to Prevent Hospitalization: A Systematic Review and Meta-Analysis
Todd C. Lee, Simone Vigod, Émilie Bortolussi-Courval, Ryan Hanula, David R. Boulware, Eric J. Lenze, Angela M. Reiersen, Emily G. McDonald
medRxiv 2021.12.17.21268008; doi: https://doi.org/10.1101/2021.12.17.21268008
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area